TGF-β Suppresses COX-2 Expression by Tristetraprolin-Mediated RNA Destabilization in A549 Human Lung Cancer Cells

Soyeong Kang1, Ahrum Min1, Seock-Ah Im2

  • 1Cancer Research Institute, Seoul National University, Seoul, Korea.

Abstract

Insights

Transforming growth factor β (TGF-β) suppresses cyclooxygenase 2 (COX-2) in lung cancer cells by degrading its mRNA. This process involves Smad3 and tristetraprolin (TTP), highlighting a novel regulatory pathway.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Cyclooxygenase 2 (COX-2) overexpression promotes cancer cell survival.
  • Transforming growth factor β (TGF-β) typically inhibits epithelial cell proliferation.

Purpose of the Study:

  • To investigate if TGF-β regulates COX-2 expression in A549 human lung adenocarcinoma cells.
  • To elucidate the mechanism of TGF-β-mediated COX-2 regulation.

Main Methods:

  • Western blotting and Northern blotting to assess protein and mRNA levels.
  • mRNA stability assays (actinomycin D chase) to determine degradation rates.
  • RNA interference to evaluate the role of tristetraprolin (TTP).

Main Results:

  • TGF-β significantly suppressed both COX-2 mRNA and protein expression.
  • TGF-β treatment led to more rapid degradation of COX-2 mRNA, indicating reduced stability.
  • TGF-β induced TTP expression, which was essential for COX-2 mRNA destabilization.
  • Smad3 was identified as crucial for TTP-dependent COX-2 down-regulation.

Conclusions:

  • TGF-β down-regulates COX-2 expression in A549 cells through mRNA destabilization.
  • The Smad3/TTP pathway mediates TGF-β's inhibitory effect on COX-2 expression.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.5K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
9.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.9K